Monthly Archives: February 2021

Study of entire French population offers further data on cyproterone acetate and meningioma risk

Posted on February 28, 2021 by Zinnia Jones

Previously: Cyproterone acetate and meningioma risk in trans women (March 2018) Update on case reports: Cyproterone acetate and meningioma in trans women (November 2018) Lower doses of cyproterone acetate may be similarly effective for blocking testosterone, with a lower risk … Continue reading →

Posted in Antiandrogens, Endocrinology, Oncology, Progestogens | Tagged , , | Leave a comment

First report of trans man having successful fertility preservation without interrupting HRT

Posted on February 28, 2021 by Zinnia Jones

Previously: Fertility treatment for trans men: Prior testosterone use does not affect ovarian stimulation outcomes (November 2019) Ovarian stimulation after testosterone use: Successful fertility preservation with less than a month’s interruption of HRT (April 2020) Successive studies have worked to … Continue reading →

Posted in Endocrinology, Fertility and reproduction, Transmasculine | Tagged , | Leave a comment

Proxalutamide, a new antiandrogen, improves COVID-19 outcomes in trials of men and women

Posted on February 28, 2021 by Zinnia Jones

Previously: COVID-19 updates: From spironolactone to estrogen to GnRH antagonists (May 2020) Disclaimer: I am not a medical professional and this is not medical advice. The COVID-19 pandemic continues to be a rapidly evolving situation, and this information may be … Continue reading →

Posted in Antiandrogens, COVID-19, Endocrinology | Tagged , , | Leave a comment

Trans men and transmasculine people can get effective vocal pitch surgery too

Posted on February 1, 2021 by Zinnia Jones

I’ve previously posted about studies of vocal deepening among trans men and transmasculine people on testosterone and the range of results that are achieved. Voice pitch deepening under the effects of testosterone is a one-way process – testosterone deprivation or … Continue reading →

Posted in Endocrinology, Outcomes of transition, Surgery, Transmasculine, Voice | Tagged , | Leave a comment